EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Anti-inflammatory agents other than corticosteroid in SARs-CoV-2 pneumonia

Pongdhep Theerawit

Clinical Critical Care · 2021

DOI: 10.54205/ccc.v29i.252686 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Critical Care, 2021. Verfasst von Pongdhep Theerawit. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The SARs-CoV-2 results in hyperinflammation among infected patients. This condition leads to serious organ injury, especially in the lungs. Therefore, the main treatment option, in addition to anti-viral agents, is the administration of corticosteroids. However, in many cases, inadequate response to corticosteroids has been observed—other anti-inflammatory agents, such as interleukin-6 inhibitor, kinase inhibitor, etc., play an essential role in reducing this severe complication.

Zitieren

APA

Theerawit, P. (2021). Anti-inflammatory agents other than corticosteroid in SARs-CoV-2 pneumonia. Clinical Critical Care. https://doi.org/10.54205/ccc.v29i.252686

Vancouver

Theerawit P. Anti-inflammatory agents other than corticosteroid in SARs-CoV-2 pneumonia. Clinical Critical Care. 2021. doi:10.54205/ccc.v29i.252686

BibTeX
@article{Theerawit2021,
  author = {Theerawit, Pongdhep},
  title = {Anti-inflammatory agents other than corticosteroid in SARs-CoV-2 pneumonia},
  journal = {Clinical Critical Care},
  year = {2021},
  doi = {10.54205/ccc.v29i.252686}
}
Kostenlos starten →